Skip to main content
. 2019 Jul 12;19:614. doi: 10.1186/s12879-019-4250-6

Fig. 2.

Fig. 2

ALT, AST, TBIL and HBV DNA levels at baseline and at delivery. Panel a was ALT, panel b was AST, panel c was TBIL, and panel d was HBV DNA.* means P < 0.05, compared with that before the treatment in the same drug group